Arthritis Foundation 2012 Innovative Research Grant Awardees
The recipients of the Arthritis Foundation’s Innovative Research Grants for 2012 highlight our commitment to driving research studies that: target personalized treatments for individual RA and JA patients; create and utilize a national registry for JA patients; and identify biomarkers that will allow for earlier diagnosis and treatment of OA. We are proud of all of our 2012 IRG awardees.
In the Field of Rheumatoid Arthritis Research
Soumya Raychaudhuri, MD, PhD
Brigham and Women’s Hospital
RA Risk Alleles Influence Function of CD4 Positive Effector Memory Cells
Shiva Shahrara, PhD
University of Illinois – Chicago
The Novel Role of CCL21 and CCR7 in RA Pathogenesis
Gregg Silvermann, MD
New York University School of Medicine
Anti-citrillinated Epitope B Cells and RA Pathogenesis
Michael Stein, M.B., Ch.B.
Vanderbilt University Medical Center
Inflammation and the Heart
In the Field of Juvenile Arthritis Research
Yukiko Kimura, MD
Hackensack University Medical Center
Implementing CARRA Standardized Treatment Plans for JIA
Suzanne C. Li, MD, PhD
Hackensack University Medical Center
Developing Tools for Localized Scleroderma Comparative Effectiveness Studies
Laura Schanberg, MD
Duke University Medical Center
Pre-Mote: An Electronic Self-Management Intervention for Pain in JIA
Anne Marguerite Stevens, MD, PhD
Seattle Children’s Hospital
Immune Response to Oral Pathogens in Juvenile Idiopathic Arthritis
In the Field of Osteoarthritis Research
Andres Jose Garcia, PhD
Georgia Tech Research Corporation
IL-1Ra-Tethered Nanoparticles to Treat Joint Inflammation and OA
Dominik Haudenschild, PhD
University of California, Davis
Preventing PTOA After ACL Injury in a Non-invasive Mouse Model
Virginia Byers Kraus, MD, PhD
Duke University Medical Center
Post-translationally Modified Proteins as Biomarkers of OA
Christian Latterman, MD
University of Kentucky Research Foundation
IL-1RA Treatment in Patients with Acute ACL Tear and Painful Effusions
Naomi Nakayama, PhD
The University of Texas Health Science Center at Houston
Making the hES/iPS Cell-derived Chondroprogenitor a Novel Therapeutic Tool
Neil Segal, MD
The University of Iowa
Early Targeting of Knee Osteoarthritis: Predictive Value of Contact Stress
Patrick Smits, PhD
Children’s Hospital Boston
Transcriptional Control of Articular Cartilage Specific Gene Expression
Hui B. Sun, PhD
Albert Einstein College of Medicine of Yeshiva University
Maintaining Cartilage Integrity in OA by Mechanical Intervention
More From This Issue
Research Spotlight: Dr. Michael Stein
Many People With RA Still Don’t Exercise
More Weight Equals More Fibromyalgia Pain
Metal Hips Fail Faster, Raise Health Concernsy


